These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28843919)

  • 1. Gene copy number variation and protein overexpression of EGFR and HER2 in distal extrahepatic cholangiocarcinoma.
    Jung MJ; Woo CG; Lee S; Chin S; Kim HK; Kwak JJ; Koh ES; Lee B; Jang KT; Moon A
    Pathology; 2017 Oct; 49(6):582-588. PubMed ID: 28843919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of EGFR family gene aberrations in cholangiocarcinoma.
    Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B
    Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.
    Birkman EM; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
    BMC Cancer; 2016 Jul; 16():406. PubMed ID: 27387915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
    Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
    Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
    Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
    Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N; Grenert JP; Sahai V; Kakar S
    Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study.
    Sneige N; Hess KR; Multani AS; Gong Y; Ibrahim NK
    Cancer; 2017 Apr; 123(7):1115-1123. PubMed ID: 27893937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.
    Lee HJ; Seo AN; Kim EJ; Jang MH; Kim YJ; Kim JH; Kim SW; Ryu HS; Park IA; Im SA; Gong G; Jung KH; Kim HJ; Park SY
    Br J Cancer; 2015 Jan; 112(1):103-11. PubMed ID: 25349977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
    Ha SY; Lee J; Jang J; Hong JY; Do IG; Park SH; Park JO; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Kang WK; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1629-35. PubMed ID: 25157953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma.
    Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT
    Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
    Yoshikawa D; Ojima H; Iwasaki M; Hiraoka N; Kosuge T; Kasai S; Hirohashi S; Shibata T
    Br J Cancer; 2008 Jan; 98(2):418-25. PubMed ID: 18087285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
    Lee HJ; Chung JY; Hewitt SM; Yu E; Hong SM
    Virchows Arch; 2012 Nov; 461(5):521-30. PubMed ID: 23052372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis.
    Albrecht T; Rausch M; Rössler S; Albrecht M; Braun JD; Geissler V; Mehrabi A; Vogel MN; Pathil-Warth A; Mechtersheimer G; Renner M; Rupp C; Weiss KH; Busch E; Köhler B; Springfeld C; Schirmacher P; Goeppert B
    BMC Cancer; 2019 Dec; 19(1):1191. PubMed ID: 31805897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
    Al-Saad S; Al-Shibli K; Donnem T; Andersen S; Bremnes RM; Busund LT
    J Thorac Oncol; 2010 Oct; 5(10):1536-43. PubMed ID: 20802349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protein overexpression and gene copy number of EGFR and HER2 in colorectal carcinoma].
    Zeng X; Wang P; Wu SF; Gao J; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):447-52. PubMed ID: 17845756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.